Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014 · British Journal of Cancer · 578 citations
https://doi.org/10.1038/bjc.2014.199
M
Matteo Renzulli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
303
Papers
5.9K
Citations
39
h-index
116
i10-index
Matteo Renzulli is an academic researcher from Ospedale G.B. Morgagni - L.Pierantoni. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation. The author has an h-index of 39, co-authored 258 publications.
ORCID: 0000-0002-1311-5670Papers by this author
worksYttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study
2016 · British Journal of Cancer · 69 citations
https://doi.org/10.1038/bjc.2016.191
Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification
2019 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-019-51303-9
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
2023 · JHEP Reports · 14 citations
https://doi.org/10.1016/j.jhepr.2023.100784
Magnetic resonance imaging of pure ovarian dysgerminoma: a series of eight cases
2021 · Cancer Imaging · 11 citations
https://doi.org/10.1186/s40644-021-00427-1
Optimization of pineapple juice amount used as a negative oral contrast agent in magnetic resonance cholangiopancreatography
2022 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-021-04609-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat